why choose us

First received: November 14, 2023

Clinical Trial: Immunosafe-CeD: Are Partially Hydrolysed Gluten Harmful to Celiac Disease Patients?

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Celiac Disease

Study Type: INTERVENTIONAL


Official Title: Towards Comprehensive Analytical Methods for Partially Hydrolysed Gluten to Assess Product Safety for Celiac Disease Patients

Brief Summary: The study will compare the immune response in CeD patients to wheat and barley gluten at high doses (1 gram), and also investigate the reponses to low dose barley gluten and also hydrolyzed, malted barley and placebo.This will be done by five one-day challenges with intervals around four weeks.

Read more